Risky business: Diabetic Clinical Trial Ends Abruptly
Late last year Novartis announced termination of ALTITUDE study with Rasilez®/ Tekturna® in high-risk patients with diabetes and renal impairment; 8,609 patients from 36 countries were involved.
Posts Tagged ‘pharmaceutical litigation’
New Year New Partner
As the world welcomed a new year, on January 1, 2012, The shareholders at Anapol Schwartz welcomed another member to their table. Gregory Spizer a non-equity partner at Anapol Schwartz became an Equity Partner and Firm Shareholder.
Prescription Drug Causes Heart Problems
In a recent New York Times article, the prescription drug Avandia was cited for causing heart problems in patients taking the medication. Avandia, commonly used for Type 2 Diabetes, was implicated in over 300 deaths in 2009. Also known as, Rosiglitazone, Avandia is also responsible for hundreds of heart attacks and heart failures.
